Social networks help control hypertension.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3580229)

Published in J Clin Hypertens (Greenwich) on November 26, 2012

Authors

Fadia T Shaya1, Viktor V Chirikov, C Daniel Mullins, Jon Shematek, Deleonardo Howard, Clyde Foster, Elijah Saunders

Author Affiliations

1: Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA. fshaya@rx.umaryland.edu

Associated clinical trials:

Social Media Use ,Online Health Information Seeking and Knowledge on Hypertension | NCT04451876

Articles cited by this

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ (2009) 17.73

The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94

A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28

The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes (2003) 3.04

Social networks and social support: implications for natural helper and community level interventions. Health Educ Q (1985) 2.90

Healthy people: a 2020 vision for the social determinants approach. Health Educ Behav (2011) 1.93

Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med (2005) 1.88

Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med (2004) 1.61

Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res (2002) 1.54

The impact of family behaviors and communication patterns on chronic illness outcomes: a systematic review. J Behav Med (2011) 1.40

Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med (2004) 1.36

Social support among African-American adults with diabetes, Part 2: A review. J Natl Med Assoc (1998) 1.17

How does health information influence African American men's health behavior? Am J Mens Health (2011) 1.03

The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens (Greenwich) (2011) 0.93

Blood pressure: the lower, the better: the con side. Diabetes Care (2011) 0.91

Social network and blood pressure: a population study. Psychosom Med (1992) 0.86

[Relationship between social network and hypertension in older people in Spain]. Rev Esp Cardiol (2005) 0.85

Partnerships for health in the African American community: moving toward community-based participatory research. J Cult Divers (2011) 0.84

Social network and health outcomes among African American cardiac rehabilitation patients. Heart Lung (2010) 0.79

Articles by these authors

Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med (2005) 5.09

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08

Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel. Pharmacotherapy (2012) 2.49

Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev (2006) 2.48

Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol (2003) 2.47

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension (2004) 1.67

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy. Am J Geriatr Cardiol (2008) 1.48

Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24

A perspective on African American participation in clinical trials. Contemp Clin Trials (2006) 1.23

The Metabolic Syndrome in African Americans: a review. Ethn Dis (2003) 1.20

Effect of social networks intervention in type 2 diabetes: a partial randomised study. J Epidemiol Community Health (2013) 1.15

Hypertension-related morbidity and mortality in African Americans--why we need to do better. J Clin Hypertens (Greenwich) (2006) 1.13

Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics. Ethn Dis (2011) 1.12

Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study. Clin Trials (2013) 1.11

Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest (2009) 1.03

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens (Greenwich) (2005) 1.02

Reasons for discharges against medical advice: a qualitative study. Qual Saf Health Care (2010) 0.99

β-Adrenergic blockers. J Clin Hypertens (Greenwich) (2011) 0.96

Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J Clin Hypertens (Greenwich) (2006) 0.94

The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens (Greenwich) (2011) 0.93

Readmissions after unauthorized discharges in the cardiovascular setting. Med Care (2011) 0.90

Addressing cardiovascular disparities through community interventions. Ethn Dis (2006) 0.89

Hypertension in black Americans as a special population: why so special? Curr Cardiol Rep (2006) 0.87

Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin. J Natl Med Assoc (2005) 0.87

Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. J Natl Med Assoc (2006) 0.87

Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. Mayo Clin Proc (2008) 0.86

Treatment of heart failure in African Americans--a call to action. J Natl Med Assoc (2011) 0.85

Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial. J Womens Health (Larchmt) (2008) 0.83

Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials. Clin Ther (2011) 0.81

Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich) (2015) 0.80

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare. Pharmacoeconomics (2014) 0.80

Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease. Ethn Dis (2009) 0.79

A qualitative evaluation of a citywide Community Health Partnership program. J Natl Med Assoc (2012) 0.78

Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. Am J Hypertens (2003) 0.78

Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus. J Clin Hypertens (Greenwich) (2009) 0.78

Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival. Value Health (2013) 0.77

Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery. J Card Surg (2006) 0.77

The metabolic syndrome: recognition and management. Dis Manag (2006) 0.77

Decision support tools to optimize economic outcomes for type 2 diabetes. Am J Manag Care (2011) 0.77

Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk. Cancer Med (2014) 0.76

Improving the quality of papers published in pharmacoeconomics and outcomes research. Value Health (2013) 0.75

A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting. BMJ Open (2012) 0.75

Diabetes control through an educational intervention. Ethn Dis (2014) 0.75

Adding a perspective to our manuscript options. Clin Ther (2009) 0.75

Health Ministry and Activities in African American Faith-Based Organizations: A Qualitative Examination of Facilitators, Barriers, and Use of Technology. J Health Care Poor Underserved (2017) 0.75

Sound public health policy: Focusing on saving the most lives possible. Clin Ther (2005) 0.75

Health care cost of analgesic use in hypertensive patients. Clin Ther (2004) 0.75

Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores. Expert Rev Pharmacoecon Outcomes Res (2005) 0.75

For the patient. What is the Metabolic Syndrome and why is it important? Ethn Dis (2003) 0.75

Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy. Expert Rev Pharmacoecon Outcomes Res (2013) 0.75

The need to address uncertainty and heterogeneity of treatment effect in clinical studies. Clin Ther (2010) 0.75

Diabetes knowledge in a high risk urban population. Ethn Dis (2011) 0.75

Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling. J Am Pharm Assoc (2003) (2016) 0.75

Home builders. Incentives, time needed to make the shift to medical homes. Mod Healthc (2008) 0.75